Diabetes in People with HIV
- PMID: 33730223
- PMCID: PMC8208107
- DOI: 10.1007/s11892-021-01382-8
Diabetes in People with HIV
Abstract
Purpose of review: To discuss the diagnosis, treatment, and complications of diabetes in people with HIV (PWH) and to review HIV-related factors that may contribute to the development of diabetes or alter decisions in the care and treatment of PWH with diabetes.
Recent findings: For those patients with atherosclerotic cardiovascular disease, heart failure, and/or chronic kidney disease, GLP-1 receptor agonists and SGLT-2 inhibitors should be considered for use. Evidence for this recommendation is, however, based on studies that were not conducted in populations consisting solely of PWH. Diabetes is a significant comorbidity in PWH and adds to their already heightened risk of cardiovascular disease. HIV-specific factors, including interactions of antiretroviral therapy with medications that either treat diabetes and/or prevent cardiovascular disease, should be evaluated.
Keywords: Antiretroviral therapy; Diabetes; HIV; Macrovascular complications; Microvascular complications.
Similar articles
-
Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus.J Am Heart Assoc. 2021 Jul 6;10(13):e021084. doi: 10.1161/JAHA.121.021084. Epub 2021 May 15. J Am Heart Assoc. 2021. PMID: 33998258 Free PMC article.
-
Combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists as complementary agents that address multi-organ defects in type 2 diabetes.Postgrad Med. 2019 Nov;131(8):555-565. doi: 10.1080/00325481.2019.1670017. Epub 2019 Oct 3. Postgrad Med. 2019. PMID: 31580737 Review.
-
Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus: focus on SGLT-2 inhibitors and GLP-1 receptor agonists.J Intern Med. 2019 Jul;286(1):16-31. doi: 10.1111/joim.12890. Epub 2019 Mar 19. J Intern Med. 2019. PMID: 30888088 Review.
-
All-cause mortality and cardiovascular outcomes with sodium-glucose Co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists and with combination therapy in people with type 2 diabetes.Diabetes Obes Metab. 2023 Oct;25(10):2897-2909. doi: 10.1111/dom.15185. Epub 2023 Jun 29. Diabetes Obes Metab. 2023. PMID: 37385958
-
Characteristics predicting the efficacy of SGLT-2 inhibitors versus GLP-1 receptor agonists on major adverse cardiovascular events in type 2 diabetes mellitus: a meta-analysis study.Cardiovasc Diabetol. 2023 Jun 28;22(1):153. doi: 10.1186/s12933-023-01877-6. Cardiovasc Diabetol. 2023. PMID: 37381019 Free PMC article.
Cited by
-
Counting, Coping, and Navigating the Flux: A Focused Ethnographic Study of HIV and Diabetes Self-Management.Qual Health Res. 2022 Feb;32(3):399-412. doi: 10.1177/10497323211064231. Epub 2021 Dec 20. Qual Health Res. 2022. PMID: 34928736 Free PMC article.
-
Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile.Open Forum Infect Dis. 2024 Mar 1;11(4):ofae112. doi: 10.1093/ofid/ofae112. eCollection 2024 Apr. Open Forum Infect Dis. 2024. PMID: 38560607 Free PMC article.
-
Effects of alcohol on the composition and metabolism of the intestinal microbiota among people with HIV: A cross-sectional study.Alcohol. 2024 Nov;120:151-159. doi: 10.1016/j.alcohol.2024.02.003. Epub 2024 Feb 20. Alcohol. 2024. PMID: 38387693 Free PMC article.
-
Prevalence and Predictors of Sleep-Disordered Breathing in Men Participating in the Multicenter AIDS Cohort Study.Chest. 2023 Mar;163(3):687-696. doi: 10.1016/j.chest.2022.10.030. Epub 2022 Nov 4. Chest. 2023. PMID: 36343689 Free PMC article.
-
Association of Cumulative Viral Load With the Incidence of Hypertension and Diabetes in People With HIV.Hypertension. 2022 Nov;79(11):e135-e142. doi: 10.1161/HYPERTENSIONAHA.122.19302. Epub 2022 Aug 23. Hypertension. 2022. PMID: 36378919 Free PMC article.
References
-
- Buchacz K, Baker RK, Palella FJ, et al. Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US. Antivir Ther. 2013;18(1):65–75. - PubMed
-
- Warriner AH, Burkholder GA, Overton ET. HIV-Related Metabolic Comorbidities in the Current ART Era. Infect Dis Clin N Am. 2014;28(3):457–+. - PubMed
-
- Noubissi EC, Katte JC, Sobngwi E. Diabetes and HIV. Curr Diabetes Rep. 2018;18(11). - PubMed
-
- Brown TT, Cole SR, Li XH, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the Multicenter AIDS Cohort Study. Arch Intern Med. 2005;165(10):1179–1184. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials